AQEMIA: Funding, Investors & Team (Sep 2026)
AQEMIA is a pharmatech company developing a drug discovery platform to discover new drugs for specific therapeutic targets. Its platform combines quantum-inspired physics and machine learning to scale the drug discovery process, generating a growing pipeline of new drug candidates.
AQEMIA has raised $75.0M across 3 funding rounds on record, the most recent an undisclosed round of $7.4M announced in Apr 2025.
That round is above the $5.7M median round size for Artificial Intelligence companies tracked on FundedIQ over the last two years.
AQEMIA Company Profile and Key Stats
Latest funding round on record: Apr 2025.
AQEMIA Funding Rounds
AQEMIA raised $29.6M in a Series A announced in Oct 2022.
2.2 years later, a Series A of $38.0M was announced in Dec 2024.
4 months later, an undisclosed round of $7.4M was announced in Apr 2025.
AQEMIA Founders and Leadership Team
Contact details for the AQEMIA team: 1 of 2 have an email address on file.
Start 14-day free trial →AQEMIA Funding Compared to Other Artificial Intelligence Startups
AQEMIA's latest round of $7.4M is above the median round in Artificial Intelligence. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like AQEMIA in Artificial Intelligence and Paris
Companies Similar to AQEMIA
Huscarl provides AI-native actuarial advisory and insurance analytics for corporate risk managers and finance…
Macrodata Labs is a technology company that provides data infrastructure for the artificial intelligence and…
Haiku is revolutionizing legal practice by placing artificial intelligence and data at the service of law.…
NotiPark is a fully automated detection and payment solution for parking spaces on public roads using…
Comand AI equips defense forces with unmatched abilities in decision-making and operations.
Reshaping the way businesses understand and leverage creator content —faster, safer, and more effective than…
Rocapine AI-native venture studio focused on developing mobile apps within the digital health and self-care…
Prophesee is the inventor of the world’s most advanced neuromorphic vision systems. Prophesee’s patented…
Kyber is an AI platform that enables teams to build and deploy AI agents that automate workflows across tools…
Alta Ares is a data integration surveillance service provider that utilizes drone imaging.
NP Company is an AI-based software simulation startup that focuses on providing realistic physics simulations.
Dust is a company offering an AI platform that allows businesses to create and implement personalized virtual…
AQEMIA Funding FAQs
What does AQEMIA do?
AQEMIA is a pharmatech company developing a drug discovery platform to discover new drugs for specific therapeutic targets. Its platform combines quantum-inspired physics and machine learning to scale the drug discovery process, generating a growing pipeline of new drug candidates.
How much funding has AQEMIA raised?
AQEMIA has raised $75.0M across 3 rounds on record. The most recent is an undisclosed round of $7.4M announced in Apr 2025.
When did AQEMIA last raise funding?
AQEMIA's most recent funding round on record is an undisclosed round of $7.4M, announced in Apr 2025.
Who founded AQEMIA?
FundedIQ lists Emmanuelle Rolland Martiano (Founder), Maximilien Levesque (Founder) at AQEMIA.
Where is AQEMIA headquartered?
AQEMIA is based in Paris, Ile-De-France, France.
How many employees does AQEMIA have?
AQEMIA is in the 51-100 employee band.
How does AQEMIA's funding compare to other Artificial Intelligence startups?
AQEMIA's latest round of $7.4M is above the $5.7M median round size for Artificial Intelligence companies on FundedIQ across 7,234 tracked companies over the last two years.
About FundedIQ's AQEMIA Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for AQEMIA is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.